Study Summary
This trial will study the effects of low-level tragus nerve stimulation on inflammatory cytokines in patients with acute decompensated heart failure.
- Acute Heart Failure
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: During the hospitalization(baseline,day 1, day 2, day 3 and day 4)
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Control group
1 of 2
Tragus Stimulation
1 of 2
Active Control
Experimental Treatment
80 Total Participants · 2 Treatment Groups
Primary Treatment: Tragus stimulation · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Do the requirements of this trial extend to individuals younger than thirty-five?
"This research requires participants to be within the age range of 18-75. For those under 18, there are 22 trials available and for seniors over 65 years old, 693 studies can be found." - Anonymous Online Contributor
Would you be able to provide information on whether this experiment is currently enrolling participants?
"The public record of clinicaltrials.gov shows that this study is actively seeking participants, beginning on September 1st 2016 and most recently updated on December 16th 2021." - Anonymous Online Contributor
How many individuals are enrolled in this experimental research?
"Indeed, the information provided on clinicaltrials.gov shows that this research is actively enrolling participants. This study was originally proposed on September 1st 2016 and has since been updated as recently as December 16th 2021. 80 patients will be welcomed at a single site to partake in this trial." - Anonymous Online Contributor
Are the requirements needed to join this medical examination within my reach?
"To take part in this medical trial, applicants must have a diagnosis of heart failure and be between 18-75 years old. 80 people are being invited to join the study." - Anonymous Online Contributor